Table 3 Clinical factors for TB infection among HIV positive adults at east and west Gojjam, northwest, Ethiopia, 2017
| Variables |
Cases n (%) N = 139 |
Controls n (%) N = 413 |
|---|---|---|
| CD4 count | ||
| ≤ 200cells/μl | 62(44.6) | 64(15.5) |
| 201-49cells/μl | 62(44.6) | 163(39.5) |
| ≥ 500 cells/μl | 15(10.8) | 186(45) |
| Hemoglobin | ||
| < 10 mg/dl | 70(50.4) | 80(19.4) |
| 10–11.99 mg/dl | 40(28.8) | 99(24) |
| ≥12 mg/dl | 29(20.8) | 234(56.6) |
| BMI | ||
| < 18.5 m2/kg | 103(74) | 125(30.3) |
| ≥18.5 m2/kg | 36(26) | 288(69.7) |
| Functional Status | ||
| Bedridden | 71(51.1) | 36(8.7) |
| Ambulatory | 33(23.7) | 92(22.3) |
| Working | 35(25.2) | 285(69) |
| CPT prophlaxysis | ||
| Yes | 82(60) | 328(79.4) |
| No | 57((40) | 85(20.6) |
| IPT prophylaxis | ||
| Yes | 42(30.2) | 148(35.8) |
| No | 97(69.8) | 265(64.2) |
| WHO Staging | ||
| Stage I/II | 38(27.3) | 273(66.1) |
| Stage III/IV | 101(72.7) | 140(33.9) |
